Authors: Ava Johnson, Elizabeth Graf, J Brooks Jackson.
Hormone therapy (HT) for vasomotor and genitourinary symptoms associated with menopause has been an effective treatment for relief of these symptoms and the prevention of bone loss and fracture, but does entail potential risks for which our understanding continually evolves with additional studies. Risks of HT are likely to be minimized if started within 10 years of menopause onset. HT, types of HT, dose, route of application, and duration of use should be individualized taking into account age, personal health risks, time since menopause, and individual preferences and quality of life issues to minimize risks and maximize benefits
View/Download pdf